Cardioprotective effect of diazoxide is mediated by activation of sarcolemmal but not mitochondrial ATP-sensitive potassium channels in mice.
Duncker
Dirk J
DJ
Verdouw
Pieter D
PD
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D002316:Cardiotonic Agents / Q000494:pharmacology*; D003981:Diazoxide / Q000494:pharmacology*; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D051379:Mice; D008928:Mitochondria / Q000378:metabolism*; D009203:Myocardial Infarction / Q000517:prevention & control; D017682:Myocardial Stunning / Q000517:prevention & control; D009336:Necrosis; D015221:Potassium Channels / Q000187:drug effects* / Q000378:metabolism; D024661:Potassium Channels, Inwardly Rectifying / Q000172:deficiency; D012107:Research Design; D012508:Sarcolemma / Q000378:metabolism*; D013997:Time Factors
D002316:Cardiotonic Agents; D015221:Potassium Channels; D024661:Potassium Channels, Inwardly Rectifying; D000255:Adenosine Triphosphate; D003981:Diazoxide